Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Cancer Investigation|June 28, 2008
FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literatureMassimiliano Berretta, Fabrizio Di Benedetto, Alessandra Bearz, et al.
International Journal of Molecular Sciences|July 14, 2023
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical ImplicationsElisa Bertoli, Elisa De Carlo, Debora Basile, et al.
BJU International|December 17, 2016
Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b studyMartin E Gore, Robert J Jones, Alain Ravaud, et al.
International Journal of Molecular Sciences|July 9, 2022
The Change in Paradigm for NSCLC Patients with EML4-ALK TranslocationAlessandra Bearz, Elisa De Carlo, Alessandro Del Conte, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel DiscussionCesare Gridelli, Marcello Tiseo, Diego Luigi Cortinovis, et al.
BMC Cancer|November 2, 2013
Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimenAlessandra Bearz, Emilio Minatel, Imad Abu Rumeileh, et al.
Anticancer Research|November 14, 2013
A retrospective analysis of two different sequences of therapy lines for advanced kidney cancerChiara Paglino, Giuseppe Procopio, Roberto Sabbatini, et al.
International Journal of Molecular Sciences|January 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic ApproachesLorenzo Foffano, Elisa Bertoli, Martina Bortolot, et al.
Oncotarget|April 11, 2018
Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experienceElisa De Carlo, Maria Chiara Del Savio, Jerry Polesel, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2007
Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational studyAlessandra Bearz, Isabella Garassino, Raffaele Cavina, et al.
Pageof 12